In Relapsed or Refractory FLT3+ AML, XOSPATA® helped prolong overall survival vs. salvage chemotherapy.1

xospata banner
xospata banner

FLT3 Prevalance & Testing

XOSPATA FLT3

PDF

Know more about FLT3 Mutation


 

Clinical trial data

XOSPATA FLT3

PDF

Asian Data


 

XOSPATA FLT3

PDF

Efficacy


 

XOSPATA FLT3

PDF

Post-Hoc Analysis from ADMIRAL and COMMODORE trials - Timing of Response

Patient resources

aarambh

PDF

Xospata Patient Access Initiative details


 

Dosing & Administration

XOSPATA Dosing video

xospata prescribing guide

Dosing and Administration Infographic

Resources

Mechanism of Action

NCCN Recommendation Video